Lineage Cell Therapeutics, Inc. (LCTX)
1.225
+0.04
(+2.94%)
USD |
NYAM |
Jun 08, 16:00
1.225
0.00 (0.00%)
After-Hours: 16:41
Lineage Cell Therapeutics Total Liabilities (Quarterly) : 56.84M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Curis, Inc. | 16.98M |
| Halozyme Therapeutics, Inc. | 2.453B |
| Agenus, Inc. | 414.44M |
| Amgen, Inc. | 83.31B |
| BioCryst Pharmaceuticals, Inc. | 1.019B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 109.53M |
| Shareholders Equity (Quarterly) | 53.88M |
| Debt to Equity Ratio | 0.0444 |
| Current Ratio | 6.893 |
| Net Debt Paydown Yield | 0.01% |